Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience.
Saved in:
| Title: | Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience. |
|---|---|
| Authors: | Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ejabbour@mdanderson.org., Castagnetti F; Institute of Hematology 'Seràgnoli', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Bardey-Kanaan M; Incyte Biosciences International Sàrl, Morges, Switzerland., Soichez R; Incyte Biosciences International Sàrl, Morges, Switzerland., Nguyen NT; Incyte Biosciences International Sàrl, Morges, Switzerland., Kelly D; Incyte Corporation, Wilmington, DE, USA., Rizzo F; Incyte Biosciences International Sàrl, Morges, Switzerland., Patos P; Incyte Biosciences International Sàrl, Morges, Switzerland., García-Gutiérrez V; Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain. |
| Source: | Drug safety [Drug Saf] 2026 Jul 18. Date of Electronic Publication: 2026 Jul 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42471499 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jabbour+E%22">Jabbour E</searchLink>; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. ejabbour@mdanderson.org.<br /><searchLink fieldCode="AU" term="%22Castagnetti+F%22">Castagnetti F</searchLink>; Institute of Hematology 'Seràgnoli', Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Bardey-Kanaan+M%22">Bardey-Kanaan M</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Soichez+R%22">Soichez R</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nguyen+NT%22">Nguyen NT</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kelly+D%22">Kelly D</searchLink>; Incyte Corporation, Wilmington, DE, USA.<br /><searchLink fieldCode="AU" term="%22Rizzo+F%22">Rizzo F</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22Patos+P%22">Patos P</searchLink>; Incyte Biosciences International Sàrl, Morges, Switzerland.<br /><searchLink fieldCode="AU" term="%22García-Gutiérrez+V%22">García-Gutiérrez V</searchLink>; Departamento de Hematología y Hemoterapia, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.; Universidad de Alcalá, Madrid, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2026 Jul 18. <i>Date of Electronic Publication: </i>2026 Jul 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42471499 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40264-026-01695-1 Languages: – Code: eng Text: English Titles: – TitleFull: Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jabbour E – PersonEntity: Name: NameFull: Castagnetti F – PersonEntity: Name: NameFull: Bardey-Kanaan M – PersonEntity: Name: NameFull: Soichez R – PersonEntity: Name: NameFull: Nguyen NT – PersonEntity: Name: NameFull: Kelly D – PersonEntity: Name: NameFull: Rizzo F – PersonEntity: Name: NameFull: Patos P – PersonEntity: Name: NameFull: García-Gutiérrez V IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 07 Text: 2026 Jul 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1942 Titles: – TitleFull: Drug safety Type: main |
| ResultId | 1 |